Metraipolis › archive › dc_b9fe4355f6fa

Adverse drug reaction reporting and monitoring: A review of global practices — Europe PMC PMID:41907923

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41907923
DOI
10.6026/973206300214435
License (as archived)
solo-consultazione
Archived
2026-11-07T15:22:48.691Z
SHA-256 of the archived text
8229c63d82e9e77558ce36ed80a6b7b2bc4d0c91ab3f4f7dbe8a1e5ae68d5108
Stable URL of this page
https://metraipolis.com/documento/dc_b9fe4355f6fa

How to cite

Adverse drug reaction reporting and monitoring: A review of global practices — Europe PMC PMID:41907923 — Europe PMC (en), https://europepmc.org/article/MED/41907923 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b9fe4355f6fa (Metraipolis archive dc_b9fe4355f6fa, sha256 8229c63d82e9e77558ce36ed80a6b7b2bc4d0c91ab3f4f7dbe8a1e5ae68d5108)
BibTeX
@misc{dcb9fe4355f6fa,
  title = {Adverse drug reaction reporting and monitoring: A review of global practices — Europe PMC PMID:41907923},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41907923},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b9fe4355f6fa; sha256 8229c63d82e9e77558ce36ed80a6b7b2bc4d0c91ab3f4f7dbe8a1e5ae68d5108},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41907923. Agents can read the archived copy with the MCP tool read_document.